Tagged Articles

sickle-cell anemia 2 articles

FDA approves first newborn screening test for intellectual disabilities

Federal drug regulators have granted approval for a first-of-its-kind blood test that can detect intellectual disabilities in infants by scanning variations in patients’ chromosomes that are linked to many developmental disorders. The laboratory test, known as CytoScan Dx Assay is made by medical technology company Affymetrix. It is the first FDA-approved test that analyzes the whole genome in a single procedure at very high resolutions. An intellectual disorder is a condition in which a person has limitations in mental functioning and skills such as communicating, taking care of him- or herself, and social skills. These limitations will cause a child ... Read More

Drug company tests OxyContin on pediatric patients

OxyContin maker Purdue Pharma is testing its potent painkiller on pediatric patients to see how the drug works in children. If the clinical trial meets federal guidelines, the company could receive an extension on its patent. The study is designed to see how OxyContin is absorbed, broken down, and eliminated in children compared to adults, and to see if the medication relieves pain in children as well as it does in adults. Researchers say that just because children are smaller, one shouldn’t assume that giving smaller doses will have the same effect in children as adults. Kids’ organs are still ... Read More